Mr. M., a 45-year-old quadriplegic, is being treated for an infected stage IV sacral pressure ulcer. The wound cultures have indicated the presence of multidrug-resistant Staphylococcus aureus (MRSA)....

Mr. M., a 45-year-old quadriplegic, is being treated for an infected stage IV sacral pressure ulcer. The wound cultures have indicated the presence of multidrug-resistant Staphylococcus aureus (MRSA). The physician has ordered intravenous vancomycin to be given every 12 hours, application of wet-to-dry dressings (twice a day) as part of the treatment, as well as a referral to the enterostomal therapist. In addition, Mr. M. is placed on contact precautions because of the MRSA. 1. What will you assess before starting the vancomycin infusion? 2. Two days later, Mr. M. complains of feeling “hot” in his face and neck, and itching in those same areas. His face and neck are flushed. What do you suspect is happening? 3. What can you do to minimize complications during vancomycin infusions? 4. The physician orders measurement of vancomycin blood levels. What is the therapeutic goal when vancomycin levels are monitored? 5. What is the single best action you can take to prevent the spread of Mr. M.’s MRSA infection?